NCT05167331

Brief Summary

The vicious circle of dental anxiety impacts major aspects of a child's quality of life. Hypnosis using distraction is one of the most common non-pharmalogical techniques in behavior and pain management in pediatric dentistry. Its value over traditional pharmalogical sedation is undeniable. This clinical study examines the application of hypnosis delivered through immersive virtual reality (VR) for anxious children ongoing dental procedures. The investigators will explore whether VR is as effective on pain and anxiety relief as a pharmacological sedation with inhalation of nitrous oxide.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 22, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 10, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2024

Completed
Last Updated

June 8, 2026

Status Verified

February 1, 2026

Enrollment Period

2.8 years

First QC Date

November 25, 2021

Last Update Submit

June 5, 2026

Conditions

Keywords

virtual realityhypnosisnitrous oxidedental anxietychild

Outcome Measures

Primary Outcomes (1)

  • Anxiolysis assessed by a standardized hetero-assessment scale (Venham Modified Scale)

    Child behavior can be assessed using the Veerkamp Modified Venham Scale (VMS). This is a scale from 0 (completely calm and relaxed patient) to 5 (distressed patient, completely disconnected). Several parameters are taken into account in this scale such as: the child's movements, crying or screaming, the possibility or not of performing the treatment. The authors have found this scale to be a reliable, easy-to-use and reproducible instrument when it comes to assessing children's behavior. This outcome measure is assessed by an external examinator with the video recording the procedures.

    5 weeks

Secondary Outcomes (3)

  • Assessment of analgesia with VR

    5 weeks

  • Assessment of children's tolerance levels to VR and pharmacological technique.

    5 weeks

  • Assessment of the impact of the child's temperament on his acceptance of nitrous oxide and RV sedations using a questionnaire and a temperament scale

    The parents answer to the questionnaire on the first visit during inclusion.

Study Arms (2)

Virtual Reality

ACTIVE COMPARATOR

* (T1) after fitting the headset to the child's face, the assistant starts the VR program chosen by the child. * (T2) Five minutes after induction, local anesthesia with the QUICKSLEEPER device is performed. The injection of a cartridge of anesthetic Articaïne SEPTANEST 1/200 000 is administered intraosseously. * (T3) After placing the rubber dam, the investigator performs restorative +/- endodontic care of the selected temporary molar. * (T4) Once the treatment is finished, the sedation is stopped and the patient rests in the chair for 5 minutes. * (T5) As soon as the investigator considers that the child is back to normal state, he can leave the office with his parents.

Device: Dispositif de RV - HYPNO VR

Nitrous oxide sedation

ACTIVE COMPARATOR

* (T1) With the nitrous oxide/oxygen inhalation system titrated to 50%/50% whose flow rate is adapted to the child's respiratory flow. The assistant is responsible for controlling the sedation. Verbal encouragement is always present to reassure the child. * (T2) Five minutes after induction, local anesthesia with the QUICKSLEEPER device is performed. The injection of a cartridge of anesthetic Articaïne SEPTANEST 1/200 000 is administered intraosseously. * (T3) After placing the rubber dam, the investigator performs restorative +/- endodontic care of the selected temporary molar. * (T4) Once the treatment is finished, the sedation is stopped and the patient rests in the chair for 5 minutes. * (T5) As soon as the investigator considers that the child is back to normal state, he can leave the office with his parents.

Drug: Nitrous Oxide inhalation

Interventions

use of Nitrous Oxide inhalation on children's anxiety during a dental treatment

Nitrous oxide sedation

use of Virtual Reality on children's anxiety during a dental treatment

Virtual Reality

Eligibility Criteria

Age7 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients aged between 7 and 10 years
  • With an indication for conservative and/or endodontic care of at least 2 temporary molars belonging to the same dental arch, unilateral or bilateral, and equivalent in terms of caries and symptoms
  • With dental anxiety
  • ASA I patients

You may not qualify if:

  • Patient with a history of MEOPA or virtual reality sedation for dental treatment
  • Patient refusing to do preoperative intra-oral x-rays
  • Patient with one of the MEOPA contraindications
  • Patient with a history of post-operative nausea vomiting or motion sickness
  • Patient with visual or hearing disorders
  • Patient presenting with a psychiatric pathology or having taken psychotropic drugs in the 8 weeks preceding the 1st visit and during the duration of the study
  • Patient with claustrophobia
  • Patient without French Social Security coverage
  • Lack of consent from the holders of parental authority to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Les Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

Related Publications (1)

  • Do NM, Maniere MC, Lefebvre F, Clauss F. Efficacy of virtual reality hypnosis versus conscious sedation with nitrous oxide in the management of dental anxiety in pediatric dentistry: protocol for a prospective randomized controlled trial. Trials. 2025 Jun 9;26(1):201. doi: 10.1186/s13063-025-08849-z.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2021

First Posted

December 22, 2021

Study Start

February 10, 2022

Primary Completion

November 12, 2024

Study Completion

November 12, 2024

Last Updated

June 8, 2026

Record last verified: 2026-02

Locations